已收盘 02-06 16:00:00 美东时间
+0.040
+0.21%
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
Barclays analyst Andrew Lazar maintains BellRing Brands (NYSE:BRBR) with a Overweight and lowers the price target from $30 to $27.
02-05 23:42
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
Bellring Brands Inc Class A (($BRBR)) has held its Q1 earnings call. Read on fo...
02-04 08:19
BellRing Brands 2026财年一季报营收5.37亿美元,同比增长0.8%;归母净利润0.44亿美元,同比下滑43.2%
02-04 06:01
BellRing Brands 2026财年一季报营收5.37亿美元,同比增长0.8%;归母净利润0.44亿美元,同比下滑42.9%
02-03 22:21
What Happened to BellRing Stock? BellRing Brands ($BRBR) investors watched bill...
02-03 20:42
BellRing Brands ( ($BRBR) ) has shared an announcement. On February 2, 2026, Be...
02-03 20:29
BellRing Brands (NYSE:BRBR) announced its Q1 earnings on Tuesday, February 3, 2...
02-03 20:08
OutlookFor fiscal year 2026, BellRing management has narrowed its previously issued guidance, as shown in the table below. As previously indicated, net sales growth is expected to accelerate beyond the first quarter as
02-03 20:02